All Arena Categories
ScienceCategory #162

CRISPR Technology & Precision Gene Editing

Base editing deaminase kinetics, prime editing reverse transcriptases, off-target cleavage assays, and viral/non-viral delivery vectors.

CURRENT CLASH: NOVEMBER 2026(Nov 1 → Dec 1)

The category itself is the competitive Arena. All posts published during this calendar month compete directly.

Competing Posts0
Clash Votes0
Master Aliases:#crispr#crispr#cas9#geneediting#baseediting#primeediting
Crown Sovereign: In Contest for November 2026

CRISPR Technology & Precision Gene Editing Clash Feed (1)

Direct post voting enabled. Cast verified tournament votes on competing theses.

Opening ThesisNeutral platform starter — no votes recorded, and not open to 1v1 challenges. Out-publish it to take the Arena.
AA
@austroclash_archive••September 2026
Active Clash

Epigenetic Rejuvenation via Targeted Partial Reprogramming in Non-Human Primates

## Research Overview Cellular senescence and epigenetic noise drive multi-organ physiological decline. While Yamanaka factor overexpression induces pluripotency, continuous expression historically triggered lethal teratoma formation in mammalian models. ### Transient mRNA Delivery Vector By utilizing lipid nanoparticles targeted to hepatic and vascular endothelial receptors with self-limiting 72-hour pulse kinetics, we achieve cellular rejuvenation while preventing full dedifferentiation. ### Quantitative Results DNA methylation profiling across 8 physiological tissues demonstrates a statistically significant 3.8-year reduction in biological age across primate cohorts with zero neoplastic incidence over 18 months of ongoing surveillance.

#biotechnology#crispr#longevity#epigenetics
0

CRISPR Technology & Precision Gene Editing — Peer-Reviewed Theses & Arguments

Seminal dialectical theses, empirical proofs, and peer review records in CRISPR Technology & Precision Gene Editing (1 thesis published).